Lung Cancer Trial, Recruiting NCT07348965 Sponsor: Guangzhou University of Traditional Chinese Medicine Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07348965
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC), confirmed by a lab test on a tissue or cell sample
  • Your lung cancer has a specific gene change (mutation) in the EGFR gene — either an "exon 19 deletion" or an "exon 21 L858R mutation" (confirm with trial site if unsure which type you have)
  • Your cancer has spread to the fluid surrounding your brain and spinal cord (called leptomeningeal metastasis), confirmed by a spinal fluid test done within 28 days before starting the trial, and there is at least one affected area that can be monitored by MRI scans
  • Your cancer got worse after being treated with a first type of targeted therapy drug (called a tyrosine kinase inhibitor or TKI)
  • You are between 18 and 85 years old (any gender)
  • Your blood counts, liver, and kidney are working well enough, as shown by standard blood tests (the trial team will check these specific levels)
  • If you are taking part in the drug absorption/processing part of the study: you have never previously been treated with a specific drug called furmonertinib
  • You are willing to follow the treatment plan, take medications as directed, and have signed a consent form agreeing to take part

Who may not be able to join:

  • You are unable to fill in the required health questionnaires at the start of the trial
  • You have a serious or uncontrolled illness alongside your cancer, such as an active infection, abnormal blood salt levels, or a bleeding problem
  • You are pregnant, breastfeeding, or planning to become pregnant during the study or within 6 months after it ends
  • You have a brain complication that needs urgent brain surgery
  • You currently have, or have previously had, another type of cancer
  • You have a serious brain condition or mental illness that would prevent you from reporting your own symptoms
  • You do not have the legal ability to make your own decisions, or there are medical or ethical reasons that would make continuing the study inappropriate
  • The trial doctors decide for any other reason that the trial is not right for you
  • You have a history of severe allergies, particularly if you had a serious allergic or adverse reaction to a TKI (targeted therapy) drug in the past

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Haibo Zhang, M.D., Guangdong Provincial Hospital of Traditional Chinese Medicine

Phone: 86-20-81887233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangzhou University of Traditional Chinese Medicine
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
30 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

LM-DCR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov